Spark 'very encouraged' by gene therapy data, targets 2021 for pivotal study By: Philadelphia Business Journal via Business Journals July 13, 2020 at 12:12 PM EDT The company's goal is to produce a hemophilia A gene therapy that demonstrates "safety, predictability, efficacy, and durability." Read More >>